Application Sponsors
ANDA 216715 | AMNEALS PHARMS | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | EQ 15MG BASE/5ML | 0 | PREDNISOLONE SODIUM PHOSPHATE | PREDNISOLONE SODIUM PHOSPHATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-10-25 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
AMNEALS PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 216715
[companyName] => AMNEALS PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"PREDNISOLONE SODIUM PHOSPHATE","activeIngredients":"PREDNISOLONE SODIUM PHOSPHATE","strength":"EQ 15MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/25\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-10-25
)
)